December 23, 2025 · Form 4 insider transaction
SUVRETTA CAPITAL MANAGEMENT, LLC bought 7,400 shares of BENITEC BIOPHARMA INC at $12.85 per share, a transaction worth $95.1K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 6 days after the transaction.
Notes are included on Exhibit 99.1.; Notes are included on Exhibit 99.1.